Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
C16 1-Deoxyceramide (m18:1/16:0)
Cat. No.:
OB0425LY-123
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
C16 1-Deoxyceramide (m18:1/16:0) is a lipid, belonging to the ceramide family, with roles important in cell signaling.
Synonyms:
1246298-56-5; N-(Hexadecanoyl)-1-deoxysphing-4-enine; C16 1-deoxyCer; Hexadecanamide,N-[(1S,2R,3E)-2-hydroxy-1-methyl-3-heptadecen-1-yl]-; C16:0 1-Deoxyceramide; C16:0 Ceramide (m18:1/16:0); Cer(m18:1/16:0
CAS No.:
1246298-56-5
Compound CID:
73242195
Formula:
C34H67NO2
Formula Weight:
521.9
Specification
Target:
Endogenous metabolite
Pathway:
Metabolic enzyme/Protease
Storage:
Storage at -20°C.
Applications:
C16 1-Deoxyceramide (m18:1/16:0) is involved in the development of obesity and type 2 diabetes (T2D) and lipid accumulation in differentiated adipocytes in vitro.
